Japan Approves GSK’s COVID-19 Antibody Drug, 2nd Treatment for Mild Cases

Health Minister Norihisa Tamura Japan approved GlaxoSmithKline’s COVID-19 antibody drug sotrovimab on September 27, making it the country’s fifth treatment for the disease and second to be made available for mildly ill patients. Health Minister Norihisa Tamura granted special emergency...read more